Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma M Groarke

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Leukemia & Lymphoma|May 21, 2024
VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic): clinical review in a rapidly emerging fieldLuan Phan, Danielle Hammond, Nathaniel R Wilson, et al.
Experimental Hematology|July 19, 2023
Effects of ruxolitinib on murine regulatory T cells are immune-context dependentNidhi Aggarwal, Ash Lee Manley, Jichun Chen, et al.
Lancet (London, England)|January 11, 2026
VEXAS syndrome: a comprehensive review of pathogenesis, clinical spectrum, and therapeutic strategiesEmma M Groarke, Benjamin Turturice, Bhavisha A Patel, et al.
Haematologica|April 29, 2021
Predicting response of severe aplastic anemia to immunosuppression combined with eltrombopagYoshitaka Zaimoku, Bhavisha A Patel, Ruba Shalhoub, et al.
British Journal of Haematology|April 21, 2020
Deficit of circulating CD19<sup>+</sup> CD24<sup>hi</sup> CD38<sup>hi</sup> regulatory B cells in severe aplastic anaemiaYoshitaka Zaimoku, Bhavisha A Patel, Sachiko Kajigaya, et al.
Blood|September 21, 2022
Efficacy of JAK1/2 inhibition in murine immune bone marrow failureEmma M Groarke, Xingmin Feng, Nidhi Aggarwal, et al.
Blood|September 15, 2021
Long-term outcomes in patients with severe aplastic anemia treated with immunosuppression and eltrombopag: a phase 2 studyBhavisha A Patel, Emma M Groarke, Jennifer Lotter, et al.
American Journal of Hematology|April 6, 2023
Alemtuzumab in relapsed immune severe aplastic anemia: Long-term results of a phase II studyNidhi Aggarwal, Ash Lee Manley, Ruba Shalhoub, et al.
American Journal of Hematology|March 21, 2022
Long-term eltrombopag for bone marrow failure depletes ironDavid J Young, Xing Fan, Emma M Groarke, et al.
Haematologica|June 1, 2023
Conditional survival and standardized mortality ratios of patients with severe aplastic anemia surviving at least one year after hematopoietic cell transplantation or immunosuppressive therapyRyotaro Nakamura, Bhavisha A Patel, Soyoung Kim, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Leukemia & Lymphoma|May 21, 2024
VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic): clinical review in a rapidly emerging fieldLuan Phan, Danielle Hammond, Nathaniel R Wilson, et al.
Experimental Hematology|July 19, 2023
Effects of ruxolitinib on murine regulatory T cells are immune-context dependentNidhi Aggarwal, Ash Lee Manley, Jichun Chen, et al.
Lancet (London, England)|January 11, 2026
VEXAS syndrome: a comprehensive review of pathogenesis, clinical spectrum, and therapeutic strategiesEmma M Groarke, Benjamin Turturice, Bhavisha A Patel, et al.
Haematologica|April 29, 2021
Predicting response of severe aplastic anemia to immunosuppression combined with eltrombopagYoshitaka Zaimoku, Bhavisha A Patel, Ruba Shalhoub, et al.
British Journal of Haematology|April 21, 2020
Deficit of circulating CD19<sup>+</sup> CD24<sup>hi</sup> CD38<sup>hi</sup> regulatory B cells in severe aplastic anaemiaYoshitaka Zaimoku, Bhavisha A Patel, Sachiko Kajigaya, et al.
Blood|September 21, 2022
Efficacy of JAK1/2 inhibition in murine immune bone marrow failureEmma M Groarke, Xingmin Feng, Nidhi Aggarwal, et al.
Blood|September 15, 2021
Long-term outcomes in patients with severe aplastic anemia treated with immunosuppression and eltrombopag: a phase 2 studyBhavisha A Patel, Emma M Groarke, Jennifer Lotter, et al.
American Journal of Hematology|April 6, 2023
Alemtuzumab in relapsed immune severe aplastic anemia: Long-term results of a phase II studyNidhi Aggarwal, Ash Lee Manley, Ruba Shalhoub, et al.
American Journal of Hematology|March 21, 2022
Long-term eltrombopag for bone marrow failure depletes ironDavid J Young, Xing Fan, Emma M Groarke, et al.
Haematologica|June 1, 2023
Conditional survival and standardized mortality ratios of patients with severe aplastic anemia surviving at least one year after hematopoietic cell transplantation or immunosuppressive therapyRyotaro Nakamura, Bhavisha A Patel, Soyoung Kim, et al.
Pageof 5